Ada, G. Vaccines and vaccination, (2001) New Engl. J. Med. 345:1042-1053.

Bachmaier, K. et al., Chlamydia infections and heart disease linked through molecular antigenic mimicry. (1999) Science 283:1335-1339.

Basu, S. et al., CD91 is a common receptor for the heat shock proteins gp96, hsp90, hsp70, and calreticulin. (2001) Immunity 14:303-313.

Beagley, K.W. and Timms, P., Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development. (2000) J. Reprod. Immunol. 48:47-68.

Boelen, A. et al., Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice. (2000) Vaccine 19:982-991.

Campbell, A.P. et al., Interaction of the receptor binding domains of Pseudomonas aeruginosa pilin stains PAK, PAO, KB7 and P1 to a cross-reactive antibody and receptor analog: Implications for synthetic vaccine design. (1997) J. Molec. Biol. 267:382-402.

Constant, S.L. et al., Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation. (2000) Eur. J. Immunol. 30:840-847.

Daugherty, A.L. et al., Epithelial application of Pseudomonas aeruginosa exotoxin A results in a selective targeting to cells in the liver, spleen and lymph node. (2000) J. Controlled Rel. 65:297-302.

Donnelly, J.J. et al., Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin. (1993) Proc. Natl. Acad. Sci. USA 90:3530-3534.

FitzGerald, D. et al, Characterization of V3 loop-Pseudomonas exotoxin chimeras; candidate vaccines for human immunodeficiency virus-1. (1998) J. Biol. Chem. 273:9951-9957

FitzGerald, D.J. and Mrsny, R.J., D.J. 2000. Novel approaches to mucosal antigen delivery. Crit. Rev. Therap. Drug Carrier Syst. 17:165-248.

Gray, G.L. et al., Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. (1984) Proc. Natl. Acad. Sci. USA 81:2645-2649.

Greensfelder, L., Polio outbreak raises questions about vaccine. (2000) Science 290: 1867-1869.

Hazes, B. et al., Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding. (2000) J. Molec. Biol. 283:1-13.

Hertle, R. et al., A dual-function vaccine for Pseudomonas aeruginosa: Characterization of chimeric exotoxin A-pilin protein. (2001) Infect. Immun. 69:6962-6969.

Kass. P.H. et al., Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. (1993) J. Am. Vet. Med. Assoc. 203:396-405.

Kaye, J.A. et al., Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. (2001) Brit. Medical J. 322:460-463.

Kelso, J.M. et al., Anaphylaxis from yellow fever vaccine. (1999) J. Allergy Clin. Immunol. 103:698-701.

Killeen, K.P. and Collier, J.R., Conformational integrity of a recombinant toxoid of Pseudomonas aeruginosa exotoxoin A containing a deletion of glutamic acid-553. (1992) Biochim. Biophys. Acta 1138:162-166.

Kuroda, M. et al., Whole genome sequencing of meticlilin-resistant Staphylococcus aureus. (2001) Lancet 357:1225-1240.

Legaard, P.K. et al., The superantigen Pseudomonas exotoxin-A requires additional functions from accessory cells for lymphocyte-T proliferation. (1991) Cell. Immunol. 135:372-382.

Lin, F-Y.C. et al., The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. (2001) N. Engl. J. Med. 344:1263-1269.

Malakoff, D., Aluminum is put on trial as a vaccine booster. (2000) Science 288:1323-1324.

Marc, E. et al., Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia. (2000) Pediatr. Infect. Dis. J. 19:706-710.

Mrsny, R.J. et al., Mucosal administration of a chimera compound composed of Pseudomonas exotoxin and the gp120 V3 loop sequence of HIV-1 induces both salivary and serum antibody responses. (1999) Vaccine 17:1425-1433.

Mrsny, R.J., Daugherty, A.L., McKee, M.L. and FitzGerald, D.J. 2002 Bacterial toxins as tools for mucosal vaccination. Pharm. Sci. Tech Today. In press

Nakagomi, T., Rotavirus infection and intussusception: a view from retrospect. (2000) Microbiol. Immunol. 44:619-628.

Ochsenbein, A.F. and Zinkernagel, R.M., Natural antibodies and complement link innate and acquired immunity. (2000) Immunol. Today 21:600-606.

Ramsay, M. Time to review policy on contradictions to vaccination. (2000) Lancet 356:1459-1460.

Ramster, B. et al., Vaccine products pipeline bulging. (2001) Drug Discovery Today 6:504.

Regner, M. and Lambert, P.-H., Autoimmunity through infection or immunization? (2001) Nature Immunol. 2:185-188.

Service, R.F., Medicine: Researchers seek new weapon against the flu. (1997) Science 275:756-757.

Simmons, C.P. et al., Immunomodulation using bacterial enterotoxins. (2001) Scand. J. Immunol. 53:218-226.

Weber, W., Germany halts tick-borne encephalitis vaccination. (2000) Lancet 356:52.

Yoshida, H. et al., Characterization of vaccine-derived polioviruses isolated from sewage and river water in Japan. (2000) Lancet 356:1461-1463.